IP Library Granted Patent US 11,090,449
Granted Patent B2
US 11,090,449 · App. 16/106,575 · Granted Aug 17, 2021

Smart inhaler device with automated dose delivery, measurement, and management

Inventors: Mehdi Hatamian (Mission Viejo, CA); Paul Edalat (Newport Beach, CA)
Assignee: Vivera Pharmaceuticals Inc.
A61M15/0066A61M15/008A61M15/0083A61M11/042A61M15/002A61M15/0003A61M15/0021A61M2205/3334A61M2205/3368A61M2205/3375A61M2205/3553A61M2205/3561A61M2205/3584A61M2205/502A61M2205/583A61M2205/60A61M2205/609A61M2205/6072A61M2205/8206A61M2205/8243
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,090,449
App. No.
16/106,575
Granted
Aug 17, 2021
Kind
B2
Abstract

A smart inhaler device includes: a flow pathway having a cartridge receptacle that is able to house a cartridge, flow meter, pump, and vaporizer; a wireless communication module; and at least one sensor that captures identifying information related to the cartridge. A method of providing a measured dose using a smart inhaler device includes: enabling dosing; measuring a provided dose; and disabling dosing. A smart inhaler system includes: a smart inhaler device; a user device; and a server.

Claims (21)

1. A smart inhaler device comprising:

a flow pathway comprising a cartridge receptacle that houses a cartridge, flow meter, pump, and vaporizer;

a wireless communication module;

at least one sensor that captures identifying information related to the cartridge;

a fingerprint scanner that captures a fingerprint;

a security module that:

receives a prescription associated with a user;

generates and stores a prescription reference file, the prescription reference file comprising:

a captured reference fingerprint associated with the user and

a prescription cartridge serial number associated with the cartridge and with the prescription; and

compares the captured fingerprint captured by the fingerprint scanner to the captured reference fingerprint associated with the user, wherein no substance is dispensed from the smart inhaler device unless:

at least a portion of the captured reference fingerprint matches at least a portion of the captured fingerprint; and

the identifying information related to the cartridge comprises a unique cartridge serial number that matches the prescription cartridge serial number; and

a storage that collects usage information related to the smart inhaler device, wherein the usage information comprises a quantity measured by the flow meter, identifying information related to the cartridge, a number of doses administered, and a timestamp associated with each administered dose.

2. The smart inhaler device of claim 1 , wherein the flow pathway further comprises an output blower that assists a vaporized substance along the flow pathway from the vaporizer to a mouth piece.

3. The smart inhaler device of claim 1 , wherein the at least one sensor comprises a camera and the identifying information comprises a graphic code.

4. The smart inhaler device of claim 1 , wherein the at least one sensor comprises a near field communication (NFC) receiver and the identifying information comprises an NFC tag.

5. The smart inhaler device of claim 1 , wherein the cartridge comprises a substance associated with the prescription, the prescription comprising at least one of a specified dose amount, dose frequency, maximum dose, maximum dose over time, and total usage period.

6. The smart inhaler device of claim 1 , wherein a metered dose is provided by using the flow meter to measure an amount of substance that is vaporized.

7. The smart inhaler device of claim 1 , wherein the cartridge comprises a storage cavity that houses a substance comprising at least one of an opioid, cannabinoid, and nicotine-based solution.

8. The smart inhaler device of claim 1 , wherein the wireless communication module communicatively couples the smart inhaler device to an external device, the external device comprising at least one of a smartphone, tablet, personal computer, server, and storage.

Assignments (2)
SECURITY INTEREST Recorded Jun 18, 2026
From: VIVERA PHARMACEUTICALS INC
To: CROMWELL CAPITAL HOLDINGS LLC
Reel/Frame 075005/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2018
From: HATAMIAN, MEHDI; EDALAT, PAUL
To: VIVERA PHARMACEUTICALS
Reel/Frame 046871/0601 →
Continuity (1)
Related Publication 20200061314A1 · Feb 27, 2020
Cited By (2)
US 12,402,660 US 12,587,381